Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort
2011

Long-term CD4+ lymphocyte response after starting HAART in U.S. Military

Sample size: 1846 publication Evidence: moderate

Author Information

Author(s): Lifson Alan R, Krantz Elizabeth M, Eberly Lynn E, Dolan Matthew J, Marconi Vincent C, Weintrob Amy C, Crum-Cianflone Nancy F, Ganesan Anuradha, Grambsch Patricia L, Agan Brian K

Primary Institution: Infectious Disease Clinical Research Program (IDCRP)

Hypothesis

Will CD4+ levels continue to increase or plateau after 4-6 years of HAART?

Conclusion

Small but positive long-term increases in CD4+ count in virally suppressed patients were observed.

Supporting Evidence

  • CD4+ count at HAART initiation was ≤ 200 cells/mm3 for 23% of participants.
  • The greatest CD4+ increases occurred in the first 6 months post-HAART.
  • CD4+ responses were poorer in those with longer time from HIV seroconversion to HAART start.
  • Viral load suppressors showed continued increases of 12-16 cells/year.
  • Clinical AIDS prior to HAART was associated with poorer CD4+ response.

Takeaway

When people with HIV start treatment early, their immune system can get better over time, even years later.

Methodology

Analyzed data from a prospective HIV military cohort study with CD4+ measurements post-HAART.

Potential Biases

Potential unmeasured confounding due to non-randomized group differences.

Limitations

The study may not represent all populations due to specific demographic factors and the healthy survivor effect.

Participant Demographics

96% male, median age 36 years.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI 122.0, 137.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-6405-8-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication